机构地区:[1]郑州大学第二附属医院,郑州450000 [2]新乡医学院第一附属医院
出 处:《山东医药》2016年第46期11-14,共4页Shandong Medical Journal
基 金:河南省科技发展计划项目(142102310300)
摘 要:目的:比较他克莫司与环磷酰胺对特发性膜性肾病(IMN)患者的疗效及性激素水平的影响。方法选择以肾病综合征为表现的IMN患者46例,分为他克莫司组28例、对照组18例。他克莫司组给予他克莫司胶囊0.05~0.1 mg/(kg·d),每天分2次空腹服用;醋酸泼尼松片起始剂量0.5 mg/(kg·d)晨起口服,1次/d,8周后减量。对照组给予环磷酰胺0.8 g静脉滴注,每2周1次;同时给予醋酸泼尼松片1.0 mg/(kg·d)晨起口服,1次/d,8周后减量。两组均治疗3个月。治疗前、治疗1个月、治疗3个月时,检测两组24 h尿蛋白定量、血浆白蛋白水平;治疗前及治疗3个月时,检测两组性激素中睾酮(T)、雌二醇(E2)、卵泡刺激素(FSH)、黄体生成素(LH)、泌乳素(PRL)、性激素结合球蛋白(SBG)水平。结果与治疗前相比,他克莫司组治疗1个月时24 h尿蛋白定量减少、血清白蛋白水平增高(P均<0.05),环磷酰胺组治疗1个月时24 h尿蛋白定量减少(P<0.05);两组治疗3个月时24 h尿蛋白定量均减少,血清白蛋白水平均增高(P均<0.05)。与环磷酰胺组相比,他克莫司组治疗1、3个月时24 h尿蛋白定量减少,血清白蛋白水平增高(P均<0.05)。与治疗前比较,两组治疗3个月时血清E2、T及SBG水平均下降,FSH及LH水平均升高(P均<0.05)。治疗3个月时,他克莫司组血清E2、T及SBG水平均高于对照组, FSH水平低于对照组(P均<0.05)。他克莫司组不良反应发生率低于对照组(P<0.05)。结论与环磷酰胺方案比较,对临床表现为肾病综合征的IMN患者选用他克莫司方案起效更快、效果更好,且对性激素的抑制作用较小。Objective To investigate the effects of tacrolimus combined with glucocorticoid on the levels of sex hor-mones in patients with idiopathic membranous nephropathy (IMN).Methods Forty-six IMN patients with the performance of nephrotic syndrome were divided into the tacrolimus group (28 cases)and the control group (18 cases).The tacrolimus group was given tacrolimus capsules 0.05-0.1 mg/(kg·d),twice a day on an empty stomach and prednisone acetate tab-lets with starting dose of 0.5 mg/(kg·d),morning orally,1 time /d,and after 8 weeks we reduced the dose.The control group was treated with 0.8 g cyclophosphamide by intravenous drip,1 time every 2 weeks,together with prednisone 1 mg/(kg·D)morning orally,1 time/d,and after 8 weeks we reduced the dose.These two groups were treated for 3 months. Before treatment,1 and 3 months after treatment,24 h urinary protein quantitative level and serum albumin level were de-tected in the two groups as well as the sex hormone testosterone (T),estradiol (E2),follicle stimulating hormone,luteini-zing hormone (FSH)hormone (LH),prolactin (PRL)and sex hormone binding globulin (SBG)levels.Results Com-pared with that before treatment,24-hour urinary protein quantitative level reduced,the serum albumin level increased the tacrolimus group at 1 month after treatment (all P〈0.05),and in the cyclophosphamide group at 1 month after treatment, 24-hour urinary protein quantitative level reduced (P〈0.05).At 3 months after treatment,24-hour urinary protein quanti-tative level decreased and the serum albumin level increased (all P〈0.05).Compared with the cyclophosphamide group, 24-hour urinary protein quantitative level decreased,and the serum albumin level increased in the tacrolimus group at 1 and 3 months after treatment (all P〈0.05).At 3 months after treatment,the levels of serum E2,T and SBG were decreased, and the FSH and LH levels were increased as compared with that before treatment (all P〈0.05).At 3 m
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...